-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Clearside Biomedical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
- Clearside Biomedical, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$7.59M, a 4.4% decline year-over-year.
- Clearside Biomedical, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$25.8M, a 13.1% increase year-over-year.
- Clearside Biomedical, Inc. annual Operating Income (Loss) for 2023 was -$24.8M, a 17.9% increase from 2022.
- Clearside Biomedical, Inc. annual Operating Income (Loss) for 2022 was -$30.3M, a 4729% decline from 2021.
- Clearside Biomedical, Inc. annual Operating Income (Loss) for 2021 was -$627K, a 96.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)